異種移植の世界市場レポート 2025年

異種移植の市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.6％で219億8,000万米ドルに成長します。予測期間の成長は、世界のヘルスケアインフラ、公的資金、遠隔医療、一般市民の認識と受容、AIの使用に起因すると考えられます。予測期間における主な動向は、個別化異種移植、多臓器移植、精密医療との統合、長期モニタリングソリューション、ブロックチェーンの利用などです。

組織・臓器移植の需要の高まりは、異種移植市場の成長を促進すると予想されます。多嚢胞性腎臓病、嚢胞性線維症、心臓疾患などの疾患は、多くの人に臓器移植を必要とすることが多いです。しかし、臓器移植の需要が大きいため、移植用の臓器が不足しています。異種移植は、ヒト以外の臓器をヒトの臓器の代用品として使用することで、この問題を解決する可能性を提示しています。例えば、2023年1月、米国を拠点とする非営利の科学・教育団体である臓器移植ネットワーク（United Network for Organ Sharing）は、2022年に米国で42,887件の臓器移植が行われ、2021年から3.7％増加し、年間新記録を樹立したと報告しました。このため、組織・臓器移植の需要拡大が異種移植市場の成長促進要因になると予測されます。

外科手術の増加は、今後の異種移植市場の拡大を牽引すると予測されています。このような処置には、医学的状態の診断や対処のための手動または機器による方法が含まれます。ある種から別の種への臓器、組織、細胞の移植を伴う異種移植は、外科手術の領域に革命をもたらす大きな可能性を秘めています。移植可能な人間の臓器が不足しているため、異種移植は代替ソリューションとして浮上しています。例えば、2022年4月、美容形成外科を専門とする最高組織であるThe Aesthetic Societyが報告したように、外科手術は前年と比較して54％急増し、非外科手術は44％増加しました。その結果、手術件数の増加が異種移植市場の成長を支える重要な要因となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の異種移植 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の異種移植市場：成長率分析
• 世界の異種移植市場の実績：規模と成長, 2019-2024
• 世界の異種移植市場の予測：規模と成長, 2024-2029, 2034F
• 世界の異種移植総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の異種移植市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 臓器保存ソリューション
• 移植診断
• 組織製品
• 世界の異種移植市場：治療別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 鎮痛剤
• 免疫抑制剤
• その他の治療
• 世界の異種移植市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 心臓
• 腎臓
• その他の臓器
• 世界の異種移植市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 移植センター
• その他のエンドユーザー
• 世界の異種移植市場、タイプ別サブセグメンテーション：臓器保存ソリューション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 低温保存ソリューション
• 常温保存ソリューション
• 臓器保管ソリューション
• 世界の異種移植市場、タイプ別サブセグメンテーション：移植診断、実績と予測, 2019-2024, 2024-2029F, 2034F
• 移植前適合性検査
• 移植後のモニタリング
• 分子診断
• 世界の異種移植市場、タイプ別サブセグメンテーション：組織製品、実績と予測, 2019-2024, 2024-2029F, 2034F
• 異種移植組織製品
• 組織工学製品
• 生物学的足場

第7章 地域別・国別分析

• 世界の異種移植市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の異種移植市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 異種移植市場：競合情勢
• 異種移植市場：企業プロファイル
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • Astellas Pharma Overview, Products and Services, Strategy and Financial Analysis
  • United Therapeutics Overview, Products and Services, Strategy and Financial Analysis
  • Preservation Solutions Overview, Products and Services, Strategy and Financial Analysis
  • OrganOX Limited Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Talaris Therapeutics
• TransMedic Inc.
• Sernova Corp
• Nova Lung
• Recombinetics
• Tissue Regenix
• TissueGene
• SAB Biotherapeutics
• eGenesis
• Revivicor
• Organ Recovery Systems
• CRISPR Therapeutics
• Qihan Biotech
• Sino-Clone Organ Biotechnology
• Xenothera

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 異種移植市場2029：新たな機会を提供する国
• 異種移植市場2029：新たな機会を提供するセグメント
• 異種移植市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Xenotransplantation involves transplanting nonhuman animal cells, tissues, or organs into humans, or vice versa, including ex vivo contact between human and nonhuman animal tissues.

The main products in the field of xenotransplantation include organ preservation solutions, transplant diagnostics, and tissue products. Organ preservation solutions are designed to reduce ischemic and hypoxic damage during cold storage, thereby enhancing graft survival. This category encompasses techniques such as machine perfusion, in situ core cooling, and various organ preservation fluids. Treatments related to xenotransplantation involve the use of analgesics, immunosuppressants, and other therapeutic approaches applicable to organs such as the heart and kidney. End-users of xenotransplantation products include hospitals, transplant centers, and other relevant institutions.

The xenotransplantation market research report is one of a series of new reports from The Business Research Company that provides xenotransplantation market statistics, including xenotransplantation industry global market size, regional shares, competitors with a xenotransplantation market share, detailed xenotransplantation market segments, market trends and opportunities, and any further data you may need to thrive in the xenotransplantation industry. This xenotransplantation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The xenotransplantation market size has grown strongly in recent years. It will grow from $14.68 billion in 2024 to $15.82 billion in 2025 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to growing demand for organ transplant, animal breeding, clinical trials, developments in regulatory approvals, surgical techniques.

The xenotransplantation market size is expected to see strong growth in the next few years. It will grow to $21.98 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to global healthcare infrastructure, public funding, telemedicine, public perception and acceptance, use of AI. Major trends in the forecast period include personalized xenotransplantation, multi-organ transplants, integration with precision medicine, long-term monitoring solutions, use of blockchain.

The rising demand for tissue and organ transplantation is expected to propel the growth of the xenotransplantation market. Diseases such as polycystic kidney disease, cystic fibrosis, and heart disorders frequently require organ transplants for many individuals. However, the significant demand for organ transplants has led to a shortage of available organs for transplantation. Xenotransplantation offers a potential solution to this issue by using nonhuman organs as substitutes for human organs. For instance, in January 2023, the United Network for Organ Sharing, a US-based non-profit scientific and educational organization, reported that the United States performed 42,887 organ transplants in 2022, reflecting a 3.7 percent increase from 2021 and establishing a new annual record. Therefore, the growing demand for tissue and organ transplantation is anticipated to be a key driver of the xenotransplantation market's growth.

The rise in surgical procedures is anticipated to drive the expansion of the xenotransplantation market in the future. These procedures involve manual or instrumental methods to diagnose or address medical conditions. Xenotransplantation, which involves transplanting organs, tissues, or cells from one species to another, holds significant promise for revolutionizing the realm of surgery. Due to the scarcity of human organs available for transplantation, xenotransplantation has emerged as an alternative solution. For instance, in April 2022, as reported by The Aesthetic Society, a premier organization dedicated to aesthetic plastic surgery, surgical procedures surged by 54%, while non-surgical procedures increased by 44% compared to the previous year. Consequently, the increasing number of surgical procedures is a key driver behind the growth of the xenotransplantation market.

Major companies in the xenotransplantation market are introducing new technologies, such as preservation technology, to enhance the preservation methods and efficiency for delicate organs. Preservation technology encompasses various tools and methodologies used to protect and maintain the integrity of valuable objects, information, or environments over time. For example, in January 2022, XVIVO, a Sweden-based medical technology company focused on developing optimized solutions for organ, tissue, and cell preservation, introduced an innovative technique for efficiently storing and transporting donated hearts. The organ shortage is a significant challenge facing the transplant industry, limiting the number of patients with end-stage heart disease who receive transplant opportunities. This shortage leads to many patients passing away while awaiting a suitable organ. Xenotransplantation, which involves transplanting organs between different species, is one potential approach to address this severe scarcity. A recent groundbreaking study utilizing XVIVO's heart preservation technology achieved long-term survival following the xenotransplantation of gene-modified pig hearts into primates. This advancement holds promise for addressing the organ shortage crisis and improving transplant outcomes.

Major companies in the xenotransplantation market are prioritizing strategic partnerships to deliver reliable services to their customers. A strategic partnership is an arrangement between two or more companies or organizations that collaborate to achieve their respective goals. For example, in April 2023, Karius, a US-based company and a global leader in liquid biopsy for infectious diseases, formed a partnership with eGenesis, Inc., a US-based biotechnology company at the forefront of xenotransplantation research. The purpose of this collaboration is to develop human-compatible organs and cells for treating organ failure. By leveraging Karius's platform, which is capable of identifying and measuring diseases present in organ donors from pigs, the partnership aims to create a more comprehensive testing platform for microbial cell-free DNA. This platform will serve as the basis for surveillance and monitoring before and after transplantation, ultimately contributing to the alleviation of organ shortages and accelerating the availability of safe xenotransplantation.

In October 2023, United Therapeutics Corporation, a US-based biotechnology company, acquired Miromatrix Medical for $91 million. This strategic acquisition is intended to expand United Therapeutics' existing organ production initiatives, which include xenotransplantation, 3-D bioprinting, x-vivo lung perfusion, and regenerative medicine techniques. Miromatrix Medical, based in the US, is a development-stage company known for its fully implantable manufactured kidney product.

Major companies operating in the xenotransplantation market include Novartis AG, Astellas Pharma, United Therapeutics, Preservation Solutions, OrganOX Limited, Talaris Therapeutics, TransMedic Inc., Sernova Corp, Nova Lung, Recombinetics, Tissue Regenix, TissueGene, SAB Biotherapeutics, eGenesis, Revivicor, Organ Recovery Systems, CRISPR Therapeutics, Qihan Biotech, Sino-Clone Organ Biotechnology, Xenothera, Lung Biotechnology.

North America was the largest region in the xenotransplantation market in 2024. The regions covered in the xenotransplantation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the xenotransplantation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The xenotransplantation market includes revenues earned by entities by providing transplantation and diagnostics. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Xenotransplantation Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on xenotransplantation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for xenotransplantation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The xenotransplantation market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Products: Organ Preservation Solutions; Transplant Diagnostics; Tissue Products
• 2) By Treatment: Analgesic; Immunosuppressant; Other Treatments
• 3) By Applications: Heart; Kidney; Other Organs
• 4) By End-Users: Hospitals; Transplant Centers; Other End-Users
• Subsegments:
• 1) By Organ Preservation Solutions: Hypothermic Preservation Solutions; Normothermic Preservation Solutions; Organ Storage Solutions
• 2) By Transplant Diagnostics: Pre-Transplant Compatibility Testing; Post-Transplant Monitoring; Molecular Diagnostics
• 3) By Tissue Products: Xenograft Tissue Products; Tissue Engineered Products; Biological Scaffolds
• Companies Mentioned: Novartis AG; Astellas Pharma; United Therapeutics; Preservation Solutions; OrganOX Limited
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Xenotransplantation Market Characteristics

3. Xenotransplantation Market Trends And Strategies

4. Xenotransplantation Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Xenotransplantation Growth Analysis And Strategic Analysis Framework

• 5.1. Global Xenotransplantation PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Xenotransplantation Market Growth Rate Analysis
• 5.4. Global Xenotransplantation Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Xenotransplantation Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Xenotransplantation Total Addressable Market (TAM)

6. Xenotransplantation Market Segmentation

• 6.1. Global Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Organ Preservation Solutions
• Transplant Diagnostics
• Tissue Products
• 6.2. Global Xenotransplantation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Analgesic
• Immunosuppressant
• Other Treatments
• 6.3. Global Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Heart
• Kidney
• Other Organs
• 6.4. Global Xenotransplantation Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Transplant Centers
• Other End-Users
• 6.5. Global Xenotransplantation Market, Sub-Segmentation Of Organ Preservation Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hypothermic Preservation Solutions
• Normothermic Preservation Solutions
• Organ Storage Solutions
• 6.6. Global Xenotransplantation Market, Sub-Segmentation Of Transplant Diagnostics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pre-Transplant Compatibility Testing
• Post-Transplant Monitoring
• Molecular Diagnostics
• 6.7. Global Xenotransplantation Market, Sub-Segmentation Of Tissue Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Xenograft Tissue Products
• Tissue Engineered Products
• Biological Scaffolds

7. Xenotransplantation Market Regional And Country Analysis

• 7.1. Global Xenotransplantation Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Xenotransplantation Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Xenotransplantation Market

• 8.1. Asia-Pacific Xenotransplantation Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Xenotransplantation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Xenotransplantation Market

• 9.1. China Xenotransplantation Market Overview
• 9.2. China Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Xenotransplantation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Xenotransplantation Market

• 10.1. India Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Xenotransplantation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Xenotransplantation Market

• 11.1. Japan Xenotransplantation Market Overview
• 11.2. Japan Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Xenotransplantation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Xenotransplantation Market

• 12.1. Australia Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Xenotransplantation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Xenotransplantation Market

• 13.1. Indonesia Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Xenotransplantation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Xenotransplantation Market

• 14.1. South Korea Xenotransplantation Market Overview
• 14.2. South Korea Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Xenotransplantation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Xenotransplantation Market

• 15.1. Western Europe Xenotransplantation Market Overview
• 15.2. Western Europe Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Xenotransplantation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Xenotransplantation Market

• 16.1. UK Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Xenotransplantation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Xenotransplantation Market

• 17.1. Germany Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Xenotransplantation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Xenotransplantation Market

• 18.1. France Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Xenotransplantation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Xenotransplantation Market

• 19.1. Italy Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Xenotransplantation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Xenotransplantation Market

• 20.1. Spain Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Xenotransplantation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Xenotransplantation Market

• 21.1. Eastern Europe Xenotransplantation Market Overview
• 21.2. Eastern Europe Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Xenotransplantation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Xenotransplantation Market

• 22.1. Russia Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Xenotransplantation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Xenotransplantation Market

• 23.1. North America Xenotransplantation Market Overview
• 23.2. North America Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Xenotransplantation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Xenotransplantation Market

• 24.1. USA Xenotransplantation Market Overview
• 24.2. USA Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Xenotransplantation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Xenotransplantation Market

• 25.1. Canada Xenotransplantation Market Overview
• 25.2. Canada Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Xenotransplantation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Xenotransplantation Market

• 26.1. South America Xenotransplantation Market Overview
• 26.2. South America Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Xenotransplantation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Xenotransplantation Market

• 27.1. Brazil Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Xenotransplantation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Xenotransplantation Market

• 28.1. Middle East Xenotransplantation Market Overview
• 28.2. Middle East Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Xenotransplantation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Xenotransplantation Market

• 29.1. Africa Xenotransplantation Market Overview
• 29.2. Africa Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Xenotransplantation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Xenotransplantation Market Competitive Landscape And Company Profiles

• 30.1. Xenotransplantation Market Competitive Landscape
• 30.2. Xenotransplantation Market Company Profiles
  • 30.2.1. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Astellas Pharma Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. United Therapeutics Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Preservation Solutions Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. OrganOX Limited Overview, Products and Services, Strategy and Financial Analysis

31. Xenotransplantation Market Other Major And Innovative Companies

• 31.1. Talaris Therapeutics
• 31.2. TransMedic Inc.
• 31.3. Sernova Corp
• 31.4. Nova Lung
• 31.5. Recombinetics
• 31.6. Tissue Regenix
• 31.7. TissueGene
• 31.8. SAB Biotherapeutics
• 31.9. eGenesis
• 31.10. Revivicor
• 31.11. Organ Recovery Systems
• 31.12. CRISPR Therapeutics
• 31.13. Qihan Biotech
• 31.14. Sino-Clone Organ Biotechnology
• 31.15. Xenothera

32. Global Xenotransplantation Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Xenotransplantation Market

34. Recent Developments In The Xenotransplantation Market

35. Xenotransplantation Market High Potential Countries, Segments and Strategies

• 35.1 Xenotransplantation Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Xenotransplantation Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Xenotransplantation Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer